Literature DB >> 7945217

Analyses of truncated fibrillin caused by a 366 bp deletion in the FBN1 gene resulting in Marfan syndrome.

M Raghunath1, C M Kielty, K Kainulainen, A Child, L Peltonen, B Steinmann.   

Abstract

We studied fibrillin synthesis in cultured fibroblasts from 11 members of a three-generation family with Marfan syndrome, caused by a large in-frame deletion in FBN1 (the fibrillin gene) leading to a loss of 366 bases in the corresponding fibrillin mRNA. Metabolic labelling with [35S]Met/Cys and SDS/PAGE allowed unequivocal identification of normal and truncated fibrillin in all cell strains harbouring the deletion. In culture medium, fibrillin and its truncated counterpart were predominant, whereas their respective larger precursors were found only in traces. This proportion, however, was markedly shifted towards the normal and truncated precursors by EGTA and reversed by the addition of calcium, which confirmed the existence of profibrillin and its probably calcium-dependent conversion into fibrillin. Tunicamycin caused increased electrophoretic mobility of normal and truncated molecules without changing their apparent size differences. Intracellularly, only profibrillin was found; in the mutant cells truncated and normal profibrillin molecules were present in similar amounts and both populations were secreted and deposited simultaneously into the extracellular matrix; there, however, truncated profibrillin only became easily detectable after treatment of cells with dextran sulphate, which increased the amount of extractable profibrillin. Immunofluorescence microscopy in patients' cultures identified fibrillin-containing microfibrils which appeared to be moderately reduced both in amount and diameter. Ultrastructural analysis by rotary-shadowing and immunogold electron microscopy demonstrated the presence of numerous beaded domains reacting with fibrillin antibodies, but no intact fibrillin microfibrils in patient's cell-layer extracts, in contrast with the extensive microfibrils elaborated by control cultures. Our findings suggest, that in the patients' cell cultures all microfibrils contained the truncated fibrillin molecules.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945217      PMCID: PMC1137314          DOI: 10.1042/bj3020889

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene.

Authors:  H C Dietz; G R Cutting; R E Pyeritz; C L Maslen; L Y Sakai; G M Corson; E G Puffenberger; A Hamosh; E J Nanthakumar; S M Curristin
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

2.  Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome.

Authors:  D W Hollister; M Godfrey; L Y Sakai; R E Pyeritz
Journal:  N Engl J Med       Date:  1990-07-19       Impact factor: 91.245

3.  The effect of temperature and ionic strength on the apparent Ca-affinity of EGTA and the analogous Ca-chelators BAPTA and dibromo-BAPTA.

Authors:  S M Harrison; D M Bers
Journal:  Biochim Biophys Acta       Date:  1987-08-13

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Location on chromosome 15 of the gene defect causing Marfan syndrome.

Authors:  K Kainulainen; L Pulkkinen; A Savolainen; I Kaitila; L Peltonen
Journal:  N Engl J Med       Date:  1990-10-04       Impact factor: 91.245

6.  Preparation and assay of the intermediate filament proteins desmin and vimentin.

Authors:  E Lazarides; B L Granger
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

7.  Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes.

Authors:  B Lee; M Godfrey; E Vitale; H Hori; M G Mattei; M Sarfarazi; P Tsipouras; F Ramirez; D W Hollister
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

8.  Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome.

Authors:  K Kainulainen; L Karttunen; L Puhakka; L Sakai; L Peltonen
Journal:  Nat Genet       Date:  1994-01       Impact factor: 38.330

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils.

Authors:  L Y Sakai; D R Keene; E Engvall
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  4 in total

1.  Profibrillin-1 maturation by human dermal fibroblasts: proteolytic processing and molecular chaperones.

Authors:  Debra D Wallis; Elizabeth A Putnam; Jill S Cretoiu; Sonya G Carmical; Shi-Nian Cao; Gary Thomas; Dianna M Milewicz
Journal:  J Cell Biochem       Date:  2003-10-15       Impact factor: 4.429

Review 2.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

3.  Classical and neonatal Marfan syndrome mutations in fibrillin-1 cause differential protease susceptibilities and protein function.

Authors:  Ryan Kirschner; Dirk Hubmacher; Garud Iyengar; Jasvir Kaur; Christine Fagotto-Kaufmann; Dieter Brömme; Rainer Bartels; Dieter P Reinhardt
Journal:  J Biol Chem       Date:  2011-07-22       Impact factor: 5.157

4.  Multi-exon deletions of the FBN1 gene in Marfan syndrome.

Authors:  W Liu; I Schrijver; T Brenn; H Furthmayr; U Francke
Journal:  BMC Med Genet       Date:  2001-10-24       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.